NL-OMON56353招募中不适用
Beta-Alanine Supplementation in patients with COPD following an exercise training program to strengthen the lower limbs. - BASE-ELECTRIC
CIRO0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- COPD, GOLD group B or D (high symptomatic)
- •- Grade 3 or higher on the Modified Medical Research Council (mMRC) dyspnoea
- •- Clinically stable according to the pulmonary physician, i.e. no exacerbation
- •and/or hospitalization within the previous 4 weeks.
- •- Age between 40-80 years
- •- Cycle endurance time, measured during a constant work rate test (CWRT) at 75%
- •of the peak cycling load, is 100-300 seconds and/or Quadriceps Muscle Strength
- •(peak torque), measured with a computerized dynamometer, is less than 80% of
- •the predicted value
- •- Attending the regular inpatient pulmonary rehabilitation program in CIRO and
- •receiving NMES as the primary muscle training modality.
- •- No use of anabolic steroids during the inpatient pulmonary rehabilitation
- •program in CIRO
排除标准
- •- Instable cardiac disease
- •- Neurological disease and/or musculoskeletal disease that preclude safe
- •participation in an exercise test
- •- History of drugs/alcohol abuse in the past 10 years
- •- Vegetarianism
- •- Inability to understand the Dutch language
- •- Self-reported β-alanine supplementation in the past 3 months
- •- Participation in pulmonary rehabilitation within the past 12 months
研究者
相似试验
撤回
不适用
Beta-alanine supplementation in patients with COPD receiving non-linear periodized exercise (NLPE) training: randomized placebo-controlled trial.NL-OMON49690Radboud Universitair Medisch Centrum154
已完成
不适用
Oral β-Alanine Supplementation in Patients With COPDChronic Obstructive Pulmonary Disease (COPD)NCT02770417Hasselt University60
尚未招募
4 期
Inhaled Bronchodilators to support the use of Beta-Blockers in Chronic Obstructive Pulmonary Disease (COPD).COPDCardiac DiseaseRespiratory - Chronic obstructive pulmonary diseaseCardiovascular - Coronary heart diseaseACTRN12621001503819Waikato District Health Board36
已完成
不适用
Add-on therapy for COPD receiving inhaled bronchodilatorsCOPDJPRN-UMIN000005459EACC (Ehime Asthma COPD Conference)80
尚未招募
不适用
Beta-blockers in COPD (Chronic Obstructive Pulmonary Disease): Feasibility of a Randomised Controlled TrialACTRN12614001095651Robert Hancox48